A Guide for Planning Community-Oriented Health Care: The Health Sector Resource Allocation Model

Medical Care

Volumn 34, Issue 3, 1996, Pages 264-279

  Cowen, Mark E ^a,b   Bannister, Mary ^d   Shellenberger, Richard ^a   Tilden, Robert ^c  

^a ST JOSEPH MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d St Joseph Mercy Hospital ^*

Author keywords

Community oriented health care; Computer model; Health services research; Health status measures

Indexed keywords

ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMPUTER SIMULATION; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROMOTION; HEALTH STATUS; HUMAN; MALE; MORBIDITY; MORTALITY; ORGANIZATION AND MANAGEMENT; UNITED STATES;

CAUSE OF DEATH; COHORT STUDIES; COMMUNITY HEALTH PLANNING; COMPUTER SIMULATION; FEMALE; HEALTH CARE RATIONING; HEALTH PROMOTION; HEALTH STATUS; HUMANS; MALE; MICHIGAN; MORBIDITY; MORTALITY;

EID: 0030098952     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199603000-00006     Document Type: Article

References (112)

1. Kark SL, Kark E. An alternative strategy in community health care: Community-oriented primary health care. Isr J Med Sci 1983;19:707.
2. Mullan F. Community-oriented primary care. N Engl J Med 1982;307:1076.
3. Voelker R. Population-based medicine merges clinical care, epidemiologic techniques. JAMA 1994;271:1301.
4. Iglehart JK. Health care reform: The States. New Engl J Med 1994;330:75.
5. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716.
6. Grosse RN, deVries J, Tilden R, et al. A health development model application in rural Java. In Tilquin C, ed. Systems science in health care. Vol 1. Toronto: Pergamon Press, 1981:119.
7. Russell HC, Black RP. Evaluation of the health sector resource allocation model AID contract no. OTR-0082-C-00-2316-00, April 1983. Denver, CO: Denver Research Institute, 1983.
8. Washtenaw United Way. Needs Assessment. Ann Arbor, MI: Washtenaw United Way, 1993.
9. Inforum and Claritas Survey. Nashville TN: Inforum Inc, 1993.
10. US Bureau of the Census. Statistical abstract of the United States: 1993. 113th ed. Washington, DC: US Bureau of the Census, 1993.
11. Shyrock HS, Siegel JS. Methods and materials of demography. Washington DC: US Printing Office, US Bureau of Interior, 1971.
12. Age adjusted mortality rates: Washtenaw County 1980-1990. Lansing, MI: Michigan Department of Public Health.
13. MEDSTAT Systems, Inc., Ann Arbor, MI. Personal communication, 1994.
14. Centers for Disease Control. Mortality patterns - United States, 1991. MMWR 1993;42:897.
15. Beard CM, Kokmen E, Offord K, et al. Is the prevalence of dementia changing? Neurology 1991;41:1911.
16. Bachman DL, Wolf PA, Lin R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992;42:115.
17. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Pub Health 1994;84:1261.
18. Feldman AR, Kessler L, Myers MH, et al. The prevalence of cancer: Estimates based on the Connecticut tumor registry. N Engl J Med 1986;315:1394.
19. Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. NEJM 1993;328:1365.
20. Pesonal communication, derived from age-adjusted cancer incidences. Lansing, MI: Michigan Department of Public Health 1993.
21. Greenberg ER, Chute CG, Stukel T, et al. Social and economic factors in the choice of lung cancer treatment. N Engl J Med 1988;318:612.
22. Harris JR, Lippman ME, Veronesi U, et al. Breast cancer. NEJM 1992;327:319.
23. Epidemiologic Catchment Area Study. Cited in Myers JK, Weissman MM, Tischler GL, et al. Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psych 1984;41:959.
24. Hoffman NG, Miller NS. Perspectives of effective treatment for alcohol and drug disorders. Psych Clin NA 1993;16:127.
25. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. JAMA 1989;262:914.
26. Depression Guideline Panel. Depression in primary care, vol 2. Treatment of major depression. Clinical Practice Guideline, Number 5. AHCPR Publication No. 93-0551, April 1993. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993:54.
27. Cross-National Collaborative Group. The changing rate of major depression. JAMA 1992;268:3098.
28. National Health Interview Surveys. 1985 national ambulatory medical care survey, and 1985 vital statistics as cited in Verbrugge LM, Patrick DL. Seven chronic conditions: Their Impact on US adults' activity levels and use of medical services. Am J Pub Health 1995;85:173.
29. Hospital Discharge Rates, State of Michigan. Lansing, MI: Department of Public Health, Office of the State Registrar and Center for Health Statistics, 1993.
30. Kannel WB, Thom TJ. Incidence, prevalence and mortality of cardiovascular diseases. In Hurst JW, Schlant RC, Rackley CE, et al, eds. The heart, arteries and veins. New York, NY: McGraw-Hill, 1990;chap 37: 627.
31. Kannel WB, Doyle JT, McNaara P, et al. Precursors of sudden cardiac death. Circulation 1975;51:606.
32. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease I. Treatments following myocardial infarction. JAMA 1988;260:2088.
33. Rouleau JL, Moye LA, Pfeffer MA, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779.
34. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. Ann Int Med 1984;101:825.
35. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993;22:6A.
36. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of Captropril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. NEJM 1992;327:669.
37. SOLVD Investigators. Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. NEJM 1992;327:685.
38. National Health Interview Survey, cited in DeStefano F, Merritt RK, Anda RF, et al. Trends in nonfatal coronary heart disease in the United States, 1980 through 1989. Arch Intern Med 1993;153:2489.
39. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988;260:2259.
40. Phillips SJ, Whisnant JP, O'Fallon WM, et al. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344.
41. Wolf PA, D'Agostino RB, O'Neal A, et al. Secular trends in stroke incidence and mortality: The Framingham study. Stroke 1992;23:1551.
42. Broderick JP, Phillips SJ, Whisnant JP, et al. Incidence rates of stroke in the eighties: The end of the decline in stroke? Stroke 1989;20:577.
43. Kojima S, Omura T, Wakamatsu W, et al. Prognosis and disability of stroke patients after 5 years in Akita, Japan. Stroke 1990;21:72.
44. Garraway WM, Whisnant JP, Drury I. The changing pattern of survival following stroke. Stroke 1983;14:699.
45. National Center for Health Statistics, Drizd T, Dannenberg AL, Engel A. Blood pressure levels in persons 18-74 years of age in 1976-80, and trends in blood pressure from 1960-1980 in the United States. Vital Health Stat [11]. Washington, DC: US Government Printing Office, July 1986. DHHS publication no. (PHS) 86-1684.
46. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154.
47. Fox JP, Hall CE, Cooney MK, et al. The Seattle virus watch II. Objectives, study population and its observation, data processing and summary of illnesses. Am J Epid 1972;96:270.
48. Sleisenger MM. Irritable bowel syndrome - epidemiology. In Sleisenger MH, Fordtran JS, Scharschmidt BF, et al, eds. Gastrointestinal disease, pathophysiology, diagnosis, management, 5th ed. Philadelphia, PA: WB Saunders Company, 1993:917.
49. Laney DW, Cohen MB. Approach to the pediatric patient with diarrhea. Gastro Clin N Am 1993;22:499.
50. Gwaltney JM, Hendley JO, Simon G, et al. Rhinovirus infections in an industrial population. NEJM 1966;275:1261.
51. Abrahamson J. Hernias. In Schwartz SI, Ellis H, eds. Maingot's abdominal operations, 9th ed. Norwalk, CN: Appleton & Lange, 1989: 218.
52. Michigan Inpatient Data Base 1992. Lansing, MI: Michigan Hospital Association, 1992.
53. National Center for Health Statistics. Current estimates from the national health insurance survey 1986. Vital Health Stat 1989;10(173):NC113.
54. Sonnenberg A. Changes in physician visits for gastric and duodenal ulcers in the US during 1958-1984 as shown by National Disease and Therapeutic Index (NDTI). Digestive Diseases and Sciences 1987;32:1.
55. Vollmer WM, Osborne ML, Buist AS. Temporal trends in hospital-based episodes of asthma care in an health maintenance organization. Am Rev Respir Dis 1993;147:347.
56. Stoddard JJ, St. Peter RF, Newacheck PW. Health insurance status and ambulatory care for children. N Engl J Med 1994;330:1421.
57. Broder I, Higgins MW, Mathews KP, et al. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allerg Clin Immunol 1974;54:100.
58. Teele DW, Klein JO, Rosher B, et al. Middle ear disease and the practice of pediatrics. JAMA 1983;249:1026.
59. Office of the State Registrar and Center for Health Statistics. Live births by county: 1991. Lansing, MI: Michigan Department of Public Health, 1991. Table 26BP.
60. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin N Am 1990;17:495.
61. Barry MJ, Mulley AG, Fowler FJ, et al. Watchful waiting vs. immediate transurethral resection for symptomatic prostatism. JAMA 1988;259:3010.
62. McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign prostatic hyperplasia: Diagnosis and treatment. Clinical Practice Guideline, Number 8. Rockville, MD: Agency for Health Care Policy and Research, February 1994. AHCPR pub No. 94-0582.
63. Forrest JD, Henshaw SK. What US women think and do about contraception. Fam Plan Perspect 1983;15:157.
64. Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol 1983;118:206.
65. Klein BE, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye study. Ophthalmology 1992;99:546.
66. Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes. Ophthalmology 1985;92:1191.
67. Hillman JG. Audit of elderly people's eye problems and nonattendance at hospital eye service. BMJ 1994;308:953.
68. Sheldrick JH, Vernon SA, Wilson A, et al. Demand incidence and episode rates of ophthalmic disease in a defined urban population. BMJ 1992;305:933.
69. Podgor MJ, Cassel GH, Kannel WB. Lens changes and survival in a population-based study. NEJM 1985;313:1438.
70. Minassian DC, Mehra V, Johnson GJ. Mortality and cataract: Findings from a population-based longitudinal study. Bull WHO 1992;70:219.
71. van de Lisdonk EH, Furer JW, Kroonen AP, et al. Cataract, functioning and co-morbidity: A cross-sectional study in family practice. Fam Prac 1992;9:279.
72. Tilden R. Personal communication. Duluth, MN: Duluth Clinic, 1994.
73. Available data on blindness (update). WHO/PHL 87.14. Geneva: World Health Organization, 1987.
74. Karlson TA, Klein BEK. The incidence of acute hospital-treated eye injuries. Arch Ophthal 1986;104: 1473.
75. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma: The Beaver Dam eye study. Opthalmology 1992;99:1499.
76. Reinken J, Allan BC. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 1982;94:181.
77. Dana MR, Tielsch JM, Enger C, et al. Visual impairment in a rural Appalachian community: Prevalence and causes. JAMA 1990;264:2400.
78. Stayte M, Reeves B, Wortham C. Ocular and vision defects in preschool children. BrJ Ophthalmol 1993;77:228.
79. Perasalo R, Raitta C. The prevalence and type of glaucoma in geriatric patients. ACTA Ophthalmolgica 1992;70:308.
80. Vinding T. Visual impairment of age-related macular degeneration: An epidemiological study of 100 aged individual. ACTA Opthalmologica 1990;68:162.
81. Franks P, Clancy CM, Gold MR. Health insurance and mortality. JAMA 1993;270:737.
82. Ayanian JZ, Kohler BA, Abe T, et al. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 1993;329:326.
83. Hadley J, Steinberg EP, Feder J. Comparison of uninsured and privately insured hospital patients. JAMA 1991;265:374.
84. Fries JF, Koop CE, Beadle CE, et al. Reducing health care costs by reducing the need and demand for medical services. N Engl J Med 1993;329:321.
85. Siegel PZ, Waller MN, Frazier EL, et al. Behavioral risk factor surveillance system: Summary of data for 1991. MMWR 1993;42:23.
86. Rafferty A. Personal communication. Lansing, MI: Michigan Department of Public Health, 1992.
87. Sempos C, Fulwood R, Haines C, et al. The prevalence of high blood cholesterol levels among adults in the United States. JAMA 1989;262:45.
88. Shultz JM, Novotny TE, Rice DP. Quantifying the disease impact of cigarette smoking with SAMMEC II software. Pub Health Reports 1991;105:326.
89. Brownder WS. Estimating the impact of risk factor modification programs. J Epidemiol 1986;123: 143.
90. Morgenstern H, Bursic ES. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. J Community Health 1982;7:292.
91. Sturmans F, Mulder PGH, Valkenburg HA. Estimation of the possible effect of interventive measures in the area of ischemic heart diseases by the attributable risk percentage. Am J Epidemiol 1977;105:281.
92. Centers for Disease Control. Cigarette smoking-attributable mortality and years of potential life lost - United States, 1990. MMWR 1993;42:645.
93. Neaton JD, Wentworth D (for the Multiple Risk Factor Intervention Trial Research Group). Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch Intern Med 1992;152:56.
94. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease, Part 1. Lancet 1990;335:765.
95. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 1988;34:B60.
96. Oparil S. Antihypertensive therapy - efficacy and quality of life. N Engl J Med 1993;328:959.
97. Testa MA, Anderson RD, Nackley JF, et al. Quality of life and antihypertensive therapy in men. N Engl J Med 1993;328:907.
98. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. N Engl J Med 1993;328:914.
99. Warner KE, Wickizer TM, Wolfe RA, et al. Economic implications of workplace health promotion programs: Review of literature. J Occ Med 1988;30:106.
100. Moser M. Can the cost of care be contained and quality of care maintained in the management of hyper-tension? Arch Intern Med 1994;154:1665.
101. Edelson JT, Weinstein MC, Tosteson ANA, et al. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407.
102. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991;265:1145.
103. Weissert WG, Cready CM, Pawelak JE. The past and future of home- and community-based long-term care. Milbank Q 1988;66:309.
104. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 1992;30:473.
105. Iezzoni LI, Foley SM, Daley J, et al. Comorbidities, complications, and coding bias. JAMA 1992;267:2197.
106. Stebbens WE. Review of the validity of national coronary heart disease mortality rates. Angiology 1990;41:85.
107. Manton KG, Wrigley JM, Coehn HJ, et al. Cancer mortality, aging, and patterns of comorbidity in the United States: 1968 to 1986. J Gerontol 1991;46:S225.
108. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. JAMA 1989;262:907.
109. Mackenbach JP, Kunst AE, Lautenbach H, et al. Competing causes of death: An analysis using multiple-cause-of-death data from the Netherlands. Am J Epidemiol 1995;141:466.
110. Manton KG, Patrick CH, Stallard E. Population impact of mortality reduction: The effects of elimination of major causes of death on the "saved" population. Int J Epidemiol 1980;9:111.
111. Brennan TA. Just doctoring: Medical ethics in the liberal state. Berkeley and Los Angeles, CA: University of California Press, 1991.
112. Cohen BJ. Incorporating justice into cost-utility analyses. Med Decis Making 1993;13:383.